Document is current

Any future updates will be listed below

The metabolic fate of izencitinib, a gut-selective pan-JAK inhibitor, in humans. Identification of unusual fecal metabolites and implications for MIST evaluation

Crossref DOI link: https://doi.org/10.1007/s00044-023-03143-6

Published Online: 2023-09-09

Published Print: 2023-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark